Chinese medicine composition orally taken for curing asthma

Abstract

The invention discloses a Chinese traditional medicine composition for the treatment of asthma by internal administration. The invention is characterized in that raw material drugs producing effectivecomponents according to the following weight are that: 3g of radix glycyrrhizae preparata, 9g of Sutou, 9g of brassica alba boiss, 10g of honeysuckle, 8g of radix scutellariae, 8g of almond, 10g of cortex mori radicis, 6g of shizandra, 8g of ballonflower, 10g of dandelion and 6g of calamus. The impurity in the materials is eliminated when confecting the drug and the drug is taken by frying with water and once respectively in the morning and at night. The invention cures asthma and can calm asthma and remove phlegm with notable curative effect.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for oral administration for treating asthma, which belongs to the field of traditional Chinese medicines. Background technique [0002] Asthma is a chronic airway inflammation involving various inflammatory cells such as eosinophils, mast cells, and T lymphocytes. This airway inflammation makes the airway responsive to various provocative factors in susceptible individuals and can cause airway narrowing, manifested as recurrent wheezing, dyspnea, chest tightness, or coughing, often at night and in the morning Onset, exacerbation, and often extensive and variable reversible airflow limitation, most patients can be treated or relieved by themselves. [0003] During an asthma attack, the breathing is slow, the exhalation is deep and long, the inhalation is short, and the wheezing sound is obvious, accompanied by cyanosis, sweating, cold hands and feet, pale complexion, sometimes coughing...

AI Technical Summary

Problems solved by technology

[0005] Although the anti-inflammatory treatment of Western medicine has achieved a good effect in controlling the symptoms of asthma, inhalation administration is only a local treatment and cannot correct the allergic constitution of asthmatic patients, so asthma often recurs quickly after stopping the drug